Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Ransmayr

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Clinical Neuropharmacology|February 1, 1988
Pharmacological study in Meige's syndrome with predominant blepharospasmG Ransmayr, B Kleedorfer, R A Dierckx, et al.
Journal of Neurology|December 1, 1987
Visuoperception and visuospatial and visuorotational performance in Parkinson's diseaseG Ransmayr, B Schmidhuber-Eiler, E Karamat, et al.
Neuroscience Letters|August 15, 1994
Neurofibrillary tangles without cell loss in the lateral vestibular nucleus of patients with Alzheimer's diseaseG Ransmayr, H Benesch, C Nowakowski, et al.
Neuroscience Letters|March 2, 1990
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's diseaseP Cervera, C Duyckaerts, M Ruberg, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Slowing of high-speed memory scanning in Parkinson's disease is related to the severity of parkinsonian motor symptomsG Ransmayr, W Bitschnau, B Schmidhuber-Eiler, et al.
Neurology|May 20, 1998
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
Neuroscience Letters|May 13, 1998
Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificityJ Deckert, F Abel, G Künig, et al.
Acta Neuropathologica|November 9, 2001
Apoptosis signals in sporadic amyotrophic lateral sclerosis: an immunocytochemical studyN Embacher, W A Kaufmann, R Beer, et al.
Neuroscience Letters|March 14, 1994
Excitotoxins L-beta-oxalyl-amino-alanine (L-BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H] alpha-amino-3- hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampusG Künig, J Hartmann, B Niedermeyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 1997
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Clinical Neuropharmacology|February 1, 1988
Pharmacological study in Meige's syndrome with predominant blepharospasmG Ransmayr, B Kleedorfer, R A Dierckx, et al.
Journal of Neurology|December 1, 1987
Visuoperception and visuospatial and visuorotational performance in Parkinson's diseaseG Ransmayr, B Schmidhuber-Eiler, E Karamat, et al.
Neuroscience Letters|August 15, 1994
Neurofibrillary tangles without cell loss in the lateral vestibular nucleus of patients with Alzheimer's diseaseG Ransmayr, H Benesch, C Nowakowski, et al.
Neuroscience Letters|March 2, 1990
Tyrosine hydroxylase-like immunoreactivity in senile plaques is not related to the density of tyrosine hydroxylase-positive fibers in patients with Alzheimer's diseaseP Cervera, C Duyckaerts, M Ruberg, et al.
Journal of Neural Transmission. Parkinson'S Disease and Dementia Section|January 1, 1990
Slowing of high-speed memory scanning in Parkinson's disease is related to the severity of parkinsonian motor symptomsG Ransmayr, W Bitschnau, B Schmidhuber-Eiler, et al.
Neurology|May 20, 1998
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
Neuroscience Letters|May 13, 1998
Loss of human hippocampal adenosine A1 receptors in dementia: evidence for lack of specificityJ Deckert, F Abel, G Künig, et al.
Acta Neuropathologica|November 9, 2001
Apoptosis signals in sporadic amyotrophic lateral sclerosis: an immunocytochemical studyN Embacher, W A Kaufmann, R Beer, et al.
Neuroscience Letters|March 14, 1994
Excitotoxins L-beta-oxalyl-amino-alanine (L-BOAA) and 3,4,6-trihydroxyphenylalanine (6-OH-DOPA) inhibit [3H] alpha-amino-3- hydroxy-5-methyl-4-isoxazole-propionic acid (AMPA) binding in human hippocampusG Künig, J Hartmann, B Niedermeyer, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|October 29, 1997
Catechol-O-methyltransferase inhibition with tolcapone reduces the "wearing off" phenomenon and levodopa requirements in fluctuating parkinsonian patientsH Baas, A G Beiske, J Ghika, et al.
Pageof 8